| Price | 1,205.50p on 19-03-2026 at 19:40:08 |
|---|---|
| Change | -46.00p -3.68% |
| Buy | 1,208.50p |
| Sell | 1,207.50p |
| Last Trade: | Sell 931.00 at 1,205.50p |
| Day's Volume: | 2,037,357 |
| Last Close: | 1,205.50p |
| Open: | 1,227.50p |
| ISIN: | GB0009223206 |
| Day's Range | 1,205.50p - 1,231.00p |
| 52wk Range: | 937.80p - 1,441.50p |
| Market Capitalisation: | £10.23b |
| VWAP: | 1,211.22352p |
| Shares in Issue: | 848.99m |
Smith & Nephew (SN.) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 931 | 1,205.50p | SI Trade |
16:35:22 - 19-Mar-26 |
| Sell* | 191 | 1,205.50p | SI Trade |
16:35:22 - 19-Mar-26 |
| Sell* | 1,005,112 | 1,205.50p | Uncrossing Trade |
16:35:22 - 19-Mar-26 |
| Buy* | 164 | 1,208.00p | Automatic Execution |
16:29:50 - 19-Mar-26 |
| Buy* | 179 | 1,208.00p | Automatic Execution |
16:29:50 - 19-Mar-26 |
| Buy* | 191 | 1,208.00p | Automatic Execution |
16:29:50 - 19-Mar-26 |
| Buy* | 310 | 1,208.00p | Automatic Execution |
16:29:50 - 19-Mar-26 |
| Buy* | 9 | 1,208.00p | Automatic Execution |
16:29:50 - 19-Mar-26 |
| Buy* | 134 | 1,208.00p | Automatic Execution |
16:29:40 - 19-Mar-26 |
| Buy* | 20 | 1,208.00p | Automatic Execution |
16:29:40 - 19-Mar-26 |
Smith & Nephew (SN.) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 3:08 pm | RNS | Annual Financial Report & Notice of AGM |
| 16th Mar 2026 3:08 pm | RNS | Annual Financial Report & Notice of AGM |
| 10th Mar 2026 2:30 pm | RNS-R | Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention |
| 5th Mar 2026 7:30 am | RNS | Director Declaration |
| 2nd Mar 2026 1:36 pm | RNS | Total Voting Rights |
| 2nd Mar 2026 7:00 am | RNS | Final Results |
| 5th Feb 2026 11:56 am | RNS | Notice of Results |
| 2nd Feb 2026 4:00 pm | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 2nd Feb 2026 3:05 pm | RNS | Total Voting Rights |
| 23rd Jan 2026 2:00 pm | RNS | Director/PDMR Shareholding |